Sustained release matrix tablets of clarithromycin were prepared using different polymers as Hydroxypropyl methylcellulose (H PMC), Carbopol 934
Introduction
When designing an oral sustained release formulation, the hydrophilic matrices present an alternative to other monolithic or multi particulate pharmaceutical dosage forms. Hydrophilic matrices became extremely popular in controlling the release of drugs [I, 2, 31. Acrylic acid and cellulose derivatives may be used for hydrophilic matrices for controlled release oral delivery [4, 5, 6, 7, 8, 91 . The drug volume fraction profiles of a colored and very soluble drug, buflomedil pyridoxal phosphate, in the gel layer of initially glassy HPMC matrices were studied by Colombo et al [lo] . It was demonstrated that drug release kinetics does not only depend on drug diffusion and matrix erosion, but also on drug dissolution in the gel and on polymer relaxation. Celebi and ~n l u [ I l l evaluated hydrophilic matrix tablets of diltiazem using three grades of HPMC according to 23 factoriel design. They reported the effect of the polymer ratio on diltiazem release from matrix tablets. P6rez-Marcos et a1 [ I 21 evaluated the possible use of three types of Carbomer, with different molecular weights, in the formulation of hydrophilic furosemide matrices. Their results showed that variables associated with the type and proportion of carbomer, with insignificant effects on porosity, play an important role in the release characteristics of the active principle. The acrylic polymers Eudragit RL, RS and NE were developed for pH-independent, delayed release of active ingredients by diffusion from oral dosage forms (swellable, permeable coating and matrix structures) [13] . Metha et al [I41 investigated release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Matrix erosion and drug release followed zero order kinetics.
Clarithromycin is a semi-synthetic macrolide antibiotic. It is used in the treatment of leprosy, upper tunistic mycobacterial infections, respiratory-tract, skin and soft-tissue infections. It is given 250 mg twice daily by mouth, increased to 500 mg twice daily if required [I 5,16,17] . Hig h-performance liquid chromatography (HPLC) is routinely used for the selective and accurate determination of clarithromycin in pharmaceutical matrices [ I 8, 19, 201 . clarithromycin in different laboratories, as in a collaborative study. An important step in the validation of any analytical method is the establishment of the relationship between released % (y) and the concentration of the analyte (x) and the method may be calibrated. When correlation coefficient is above 0.9990, the assay method was acceptable. The satisfying recoveries confirm the suitability of the proposed method for the routine analysis of clarithromycin in pharmaceuticals ( Table 4 ) [23, 25, 26] . According to the results, the proposed method is able to access the analyte in the presence of common excipients and hence, it can be considered specific. Results in Table 5 indicate that clarithromycin showed good detection limit.
Tab. 3. Repeatability and precision of HPLC (clarithromycin peak response) (RSD %)
The effects of polymer type and concentration on in vitro release of clarithromycin has also been investigated. Drug release profiles are given in respectively [30] . As for the kinetic evaluations the highest determination coefficient and the best linear relation were observed for matrix tablets (F6 and F8) by Higuchi equation [31] . Graphically Higuchi distribution gave a straight line (Fig 3) .
In the present investigation, controlled release tablet forms containing different types of polymers were developed. Using different types and concentrations of polymers, controlled drug release was looked at. The effects of different polymer and concentrations, respectively, on the drug release were investigated. 
Factorial Design
The effect of HPMC (A), Carbopol 934 (B) and Eudragit RLIPO (C) was studied in separate 23 factorial experiments. The levels and variation intervals for the eight treatment combination are the calculation matrix for a Z3 factorial design, with the following combinations of factors A, B and C at two levels (3.33-10 %): (I), a, b, ab, c, ac, bc, and abc. We used 3 factors, each at only two levels in Table 6 . These levels are polymer concentrations, the "high" and "low" levels of a factors, or presence and absence of a factors [21, 22] . 
Tab. 6. Factorial design parameters and experimental conditions

Preparation of matrix tablets
Eight formulations were prepared on an instrumented single-punch tablet machine by direct compression technique. Magnesium stearate was used as the lubricant (1.0 %) and HPMC, Carbopol 934 and Eudragit RLIPO were the polymers in different concentrations (3.33-10 %). Contents of matrix tablet formulations are given in Table 7 . Each formulation was prepared separately. All ingredients of each formulation were mixed in cubic mixer. The position of the bottom punch face in the bore determines the volume of the die-cavity and hence the tablet weight. Tablet hardness was adjusted using hardness control nut.
The following tests were applied to the tablets; amount of clarithromycin, crushing strength, diameter-height ratio and friability. Tablet weight uniformity Detection and quantitation limits: The limits of detection is a parameter of limit tests. It is the lowest concentration of analyte in a sample that can be detected.
Limit of quantitation is a parameter of quantitative assays for the low levels of compounds in sample matrices, such as impurities in bulk drug substances and degradation products in finished pharmaceuticals.
In vitro dissolution studies and evaluation of release kinetics
Dissolution tests were performed according to the paddle method described in USP 26, Apparatus II. The rotating speed was 50 rpm and the temperature was 37k0.50C. Dissolution studies were carried out in 900 mL 0.1 M Sodium acetate buffer. 1 mL of samples were taken from the dissolution media at obtained from the clarithromycin matrix tablet formulations were fitted to the main models which have been proposed to describe drug release kinetics from tablets and other polymer matrices.
